Introduction {#s1}
============

Bilateral deep brain stimulation (DBS) of the subthalamic region has been identified as an effective procedure for the treatment of cardinal motor signs in advanced Parkinson's disease (PD) [@pone.0078934-Deep1]. Improvements in motor function following DBS implantation have been reported in clinical and laboratory-based outcomes. In clinical evaluations, Unified Parkinson's disease Rating Scale motor scores (UPDRS-III) have decreased 40--65 percent when treated with DBS [@pone.0078934-Chung1]--[@pone.0078934-Volkmann1]. Similarly, objectively measured (laboratory-based) motor control outcomes have also been shown to improve following DBS [@pone.0078934-Nowak1]--[@pone.0078934-Vaillancourt2]. Evidence of improvement in the control and coordination of grasping forces of goal-directed upper extremity function has been reported with DBS [@pone.0078934-Nowak1], [@pone.0078934-Alberts1]--[@pone.0078934-Vrancken1].

Despite such reports, few have ventured beyond evaluation via the UPDRS-III and basic features of unimanual prehension [@pone.0078934-Fellows1]--[@pone.0078934-Nowak2]. Assessment of motor dysfunction in activities of daily living (ADLs) is the next step in determining the extent of fine motor deficits with PD, as well as identifying how treatments, such as DBS, may alleviate impairment. Assessment of fine motor function has been recognized as a means to quantify subtle motor behavior deficits during PD progression [@pone.0078934-Pradhan1], [@pone.0078934-Gorniak1]. Impaired coordination of small motor units, unusually large grip forces, abnormal grip force production rates, and difficulty in isometric torque control have already been detected in medically managed PD [@pone.0078934-Fellows1]--[@pone.0078934-Nowak2], [@pone.0078934-Gorniak1], [@pone.0078934-Lazarus1].

Given that motor symptoms, medical side effects, and general quality of life worsen with PD progression [@pone.0078934-Behari1], [@pone.0078934-Rahman1], some patients choose to undergo DBS implantation as a means to improve quality of life. Following DBS implantation surgery, stimulation parameters that best alleviate patient motor symptoms are programmed for each implanted device [@pone.0078934-Kumar1], [@pone.0078934-Mera1]. This process of parameter programming and fine-tuning is subjective, guided by clinician intuition and experience [@pone.0078934-Mera1]. Additional subjectivity is introduced into the programming process as select items of the UPDRS rating scale are utilized to evaluate motor function [@pone.0078934-Goetz1].

While clinically determined stimulation parameters have been effective in improving overall motor function in uni- and bilaterally implanted PD patients [@pone.0078934-Chung1], [@pone.0078934-Vrancken1], declines in cognitive function have been associated with DBS [@pone.0078934-Freund1], [@pone.0078934-SaintCyr1]. As a means to mitigate DBS-induced cognitive dysfunction during clinical programming, computational software tools have been developed to optimize both cognitive and motor performance in DBS implanted patients [@pone.0078934-Mera1], [@pone.0078934-Butson1], [@pone.0078934-McIntyre1]. Recently, these model derived stimulation parameters have been found to improve indices of cognitive-motor function over clinically determined stimulation parameters in bilaterally implanted subthalamic DBS patients [@pone.0078934-Frankemolle1], without compromising motor gains based on UPDRS-III scores. Despite improvement in UPDRS-III scores with model parameters, evaluation of everyday motor function has not been included in recent investigations.

To investigate the effects of bilateral subthalamic DBS on everyday motor function, we have chosen to evaluate impairments in fine motor control using an ADL-like task to assess upper extremity function in three different stimulation conditions: clinically determined DBS parameters, patient-specific model-derived DBS parameters, and off DBS stimulation. Expanding upon the methods used in previous studies [@pone.0078934-Alberts1], [@pone.0078934-Alberts2], we have chosen to evaluate motor function in an ecological manner, by evaluating manual coordination in an ADL-like task that requires the limbs to work in together to achieve a goal [@pone.0078934-Gorniak1], [@pone.0078934-Gorniak2], [@pone.0078934-Gorniak3].

A priori, differences between the two stimulation parameter conditions are not expected, as both conditions are programmed with the intention of alleviating motor symptoms of PD. Given that improvements in manual coordination and grip force control have been reported previously with subthalamic DBS in comparison to off stimulation states [@pone.0078934-Alberts1], [@pone.0078934-Alberts2], we hypothesize that both Clinical and Model DBS states will improve overall task performance by reducing bradykinesia (Hypothesis 1) and improving grip force production (Hypothesis 2) in PD patients compared to off stimulation states. Despite our expectation of improved grip force production, no changes in grip-load force coupling due to stimulation state are expected (Hypothesis 3), as grip-load coupling has been found to be intact in PD patients independent of treatment state [@pone.0078934-Fellows2]--[@pone.0078934-Ingvarsson1]. It is also expected that the Clinical and Model DBS will reduce UPDRS-III motor scores compared to off DBS stimulation (Hypothesis 4). Specifically, we are interested in evaluating behavioral changes exhibited across the three stimulation states (clinical stimulation parameters, model-derived stimulation parameters, and off stimulation) in the same patient sample. By using tasks similar to activities of daily living (ADLs), our goal was to advance DBS programming and potentially improve manual function in tasks pertinent to performing daily activities.

Methods {#s2}
=======

Participants and Ethics Statement {#s2a}
---------------------------------

Ten participants with advanced PD participated in this study (mean ± sd: age 61±8 years), [Table 1](#pone-0078934-t001){ref-type="table"} contains patient demographics. All patients underwent bilateral subthalamic DBS implantation surgery at the Cleveland Clinic at least 10 months prior to study participation. Details regarding surgical procedures for DBS implantation, and stimulation parameter programming methods, have been previously reported [@pone.0078934-Frankemolle1], [@pone.0078934-Machado1]. Stimulation parameters used in clinical and model programming states can be found in [Table 2](#pone-0078934-t002){ref-type="table"}. For all three sessions, patients reported the laboratory in the clinically defined OFF condition (i.e. at least 12 hours since their last dose of anti-parkinsonian medications) while on DBS with their clinically derived stimulation parameters. Following arrival at the laboratory, patient stimulators were turned off for two hours prior to testing. After the two hour off-stimulation interval, DBS stimulators were programmed according to the testing state for that session. DBS stimulators were programmed a minimum of thirty minutes prior to participation in the experimental conditions.

10.1371/journal.pone.0078934.t001

###### Patient demographics, UPDRS-III scores in each of the three stimulation states, and testing session order.

![](pone.0078934.t001){#pone-0078934-t001-1}

                                  UPDRS-III Scores                
  -------- ------ ------- ------ ------------------ ------ ------ -----
  1          52     159     51           40           29     46    CMO
  2          67     136     21           29           22     40    COM
  3          73     203     57           35           29     57    COM
  4          53     207     83           38           34     59    OCM
  5          52     61      19           36           34     63    CMO
  6          54     83      13           24           24     31    CMO
  7          55     196     10           27           23     35    OMC
  8          64     261     53           18           20     49    OCM
  9          67     242     45           28           35     52    OCM
  10         67     54      32           29           24     51    COM
  *Mean*    *60*   *160*   *38*         *30*         *27*   *48*   --
  *SD*      *8*    *74*    *23*         *7*          *6*    *10*   --

10.1371/journal.pone.0078934.t002

###### Clinically-determined and patient-specific model-derived stimulation parameters for all patients.
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  Left Stimulation Parameters                                                                                                                                                                                                                                                                                                                                                                           
  ---------------------------------- ------------------------- ---------------------- ------------------------------ ------------------------ -------------------------------- --------------------------------- ----------------------- ------------- --------------------- ------------------------------ ------------------------ -------------------------------- --------------------------------- -----------------------
  DBSDT1                                       1−C+                     3.5                         90                         135                           52                               64                           116               2−C+               2.4                        60                         130                           21                               56                           77
  DBSDT2                                       3−2+                     2.9                         60                         130                           7                                18                           25                3−C+               1.6                        60                         130                           7                                35                           42
  DBSDT3                                       3+1−                     3.6                         90                         185                           4                                66                           70                2−C+               2.4                        60                         130                           12                               40                           52
  DBSDT5                                       3+1−                     3.6                         90                         185                           28                               41                           69                2−C+               1.8                        60                         130                           9                                27                           36
  DBSDT6                                       2−1+                     3.6                         90                         130                           29                               11                           40                3−C+                2                         60                         130                           16                               35                           51
  DBSDT7                                       3−2+                      3                          60                         130                           2                                23                           25                3−C+               2.2                        60                         130                           3                                51                           54
  DBSDT8                                       3+2−                     3.6                         60                         130                           13                               15                           28                2−C+               2.4                        60                         130                           39                               40                           79
  DBSDT12                                      3+1−                     3.5                         90                         185                           34                               18                           52                2−C+               1.8                        60                         130                           35                               28                           63
  DBSDT13                                      2−C+                     3.2                         60                         130                           41                               64                           105               2−C+                2                         60                         130                           28                               40                           68
  DBSDT14                                      1−C+                     3.3                         60                         130                           45                               44                           89                3−C+               2.6                        60                         130                           15                               50                           65
  **Right Stimulation Parameters**                                                                                                                                                                                                                                                                                                                                                                      
                                      ***Clinical Settings***   ***Model Settings***                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                       **VTA Volume**                                                                                                                **VTA Volume**                                                                                                     
  **Patient**                               **Contact**         **Voltage** **(V)**    **Pulse** **Width** **(µs)**   **Frequency** **(Hz)**   **Inside** **STN** **(mm^3^)**   **Outside** **STN** **(mm^3^)**   **Total** **(mm^3^)**   **Contact**   **Voltage** **(V)**   **Pulse** **Width** **(µs)**   **Frequency** **(Hz)**   **Inside** **STN** **(mm^3^)**   **Outside** **STN** **(mm^3^)**   **Total** **(mm^3^)**
  DBSDT1                                       2−C+                     3.2                         60                         135                           52                               50                           102               2−C+               1.8                        60                         130                           34                               29                           63
  DBSDT2                                       3−2+                     2.9                         60                         130                           7                                17                           24                3−C+               2.2                        60                         130                           14                               39                           53
  DBSDT3                                       2−C+                     3.6                         90                         185                           44                               94                           138               3−C+               1.6                        60                         130                           4                                36                           40
  DBSDT5                                       3+1−                     3.6                         90                         185                           34                               36                           70                2−C+               2.2                        60                         130                           31                               16                           47
  DBSDT6                                       3+1−                     3.6                         90                         130                           20                               34                           54                3−C+               2.2                        60                         130                           23                               32                           55
  DBSDT7                                       3−2+                     3.6                         60                         130                           4                                25                           29                3−C+               2.6                        60                         130                           9                                56                           65
  DBSDT8                                      3+2−1−                    3.6                         60                         130                           0                                84                           84                2−C+               1.8                        60                         130                           0                                37                           37
  DBSDT12                                      3+1−                     3.5                         90                         135                           22                               30                           52                3−C+               2.4                        60                         130                           14                               45                           59
  DBSDT13                                      3+1−                      3                          60                         130                           29                                8                           37                3−C+               1.8                        60                         130                           17                               29                           46
  DBSDT14                                      2−C+                     3.1                         60                         130                           42                               59                           101               3−C+               2.2                        60                         130                           10                               45                           55

Note that STN refers to the subthalamic nucleus.

Ethics and procedures for this study were evaluated and approved the Institutional Review Board of the Cleveland Clinic. All participants gave written informed consent according to the procedures approved by the Cleveland Clinic Institutional Review Board, in accordance with the Declaration of Helsinki. All data were collected onsite at the Cleveland Clinic, in Cleveland, Ohio, USA. None of the patients evaluated in this study exhibited cognitive issues that were significant enough to have next of kin provide informed consent. Capacity was determined via clinical cognitive evaluation using the Mini-Mental State Examination (MMSE).

Experimental Setup and Procedure {#s2b}
--------------------------------

A two-transducer system ([Figure 1](#pone-0078934-g001){ref-type="fig"}), was used to determine the time and force characteristics of bimanual tasks. The tasks involved connecting two independent objects together using one of two movements: (a) placing one object on top of another, or (b) connecting the two objects by rotating the upper object while stabilizing the lower object. Grip and load forces exerted by the hands were recorded simultaneously using force-moment transducers (Mini-40 transducers; ATI Industrial Automation, Garner, NC, USA). Two different articulation types (simple cylinder and a quarter turn screw top, referred to as *Non-Rotation* and *Rotation* tasks, respectively) between the two sensors were used throughout each testing session (Panels B and C of [Figure 1](#pone-0078934-g001){ref-type="fig"}).

![Schematics of the testing device.\
***A:*** The dynamic (upper) and static (lower) transducers are indicated. ***B:*** Depiction of the task being performed with the Non-Rotation method. ***C:*** Depiction of the task being performed with the Rotation method.](pone.0078934.g001){#pone-0078934-g001}

Participants were instructed to perform each task using only a pinch grip. Both the upper (dynamic) and lower (static) objects were freely moveable; however, the location and orientation of the static object was prescribed. Subjects were not permitted to move the static object during testing. Any trial in which movement of the static object occurred was omitted.

Overall, eight different bimanual configurations were performed in each testing session. Five trials were collected in each of the eight tested configurations (40 total trials in each session, 120 trials total). Details regarding each of the tested conditions can be found explicitly described in [@pone.0078934-Gorniak1], [@pone.0078934-Gorniak2], [@pone.0078934-Gorniak3]. Briefly, each bimanual task involved either the connecting of two separate objects into one object (Connect) or disconnecting an object into two separate objects (Disconnect). This action was performed using rotational (Rotation) and non-rotational (Non-rotation) actions of the upper/dynamic transducer.

No contact of either transducer was permitted prior to trial onset; subjects were instructed to begin each trial with both hands placed palm down on the surface of the table. Up to three practice trials were offered to each subject prior to the onset of data collection for each condition. On average, each subject performed one practice trial. In each of the three sessions, the presentation of conditions was block randomized for each subject; articulation type was used as the blocking factor.

Data were collected during three visits to the Neural Control Laboratory at the Cleveland Clinic. Each visit was separated by a minimum of 72 hours. Each participant completed the experiment under three different stimulation conditions: clinically-determined DBS parameters (Clinical), patient-specific model-derived DBS parameters (Model), and off DBS stimulation (Off).

DBS Conditions {#s2c}
--------------

The clinically-determined DBS stimulation parameters used in this study were the settings derived for each patient via standard clinical care. These settings were stable for at least 6 months prior to study participation. The clinical programming of stimulators was overseen by an experienced DBS programming team consisting of a programming nurse and a movement disorders neurologist specializing in Parkinson's disease.

Model derived stimulation parameters were defined from a patient-specific DBS computer model of each side of the patient's brain created in Cicerone v1.2, a freely available academic DBS research tool [@pone.0078934-Miocinovic1]. The details of the model development and stimulation parameter selection process are described in [@pone.0078934-Frankemolle1]. Briefly, each patient-specific DBS model included coupled integration of MRI/CT data, intra-operative electrophysiology data, 3D brain atlas surfaces, DBS electrode models, and volume of tissue activation (VTA) predictions all co-registered into the neurosurgical stereotactic coordinate system.

Based on previous experience developing patient-specific models of therapeutic subthalamic DBS [@pone.0078934-Butson1], [@pone.0078934-Maks1], a theoretical ellipsoid target volume was defined that encompassed the dorsal subthalamic nucleus and the white matter dorsal to the subthalamic nucleus [@pone.0078934-Frankemolle1]. We defined a stimulation parameter setting for each side of each patient's brain that maximized stimulation coverage of the target volume and minimized stimulation spread outside of the target volume. These model settings were defined without knowledge of the clinical stimulation settings or clinical programming notes, and based solely on customizing the stimulation to the theoretical target volume in each patient.

Model settings were defined using theoretical predictions of the VTA. The VTA provides an electrical prediction of the volume of axonal tissue directly activated by DBS for a given stimulation parameter setting. The software provided the ability to interactively visualize and evaluate a wide range of stimulation parameter settings and calculate the overlap of the VTA with the brain anatomy and target volume. Following completion of the experimental testing we used Cicerone to quantify the VTAs for each patient under both the Model and Clinical settings, along with their respective overlap with the subthalamic nucleus atlas volume available in the software.

Data Analysis {#s2d}
-------------

Grip and load forces were analyzed several different ways in this experiment. At the most basic level of analysis, the maximum magnitudes of the exerted forces were evaluated, as well as the rate of grip force production (*dF^G^/dt*) in each of the tested conditions. Total grip and load forces were considered twice the measured value as only two force-torque sensors were used in the experimental setup. Correlation between grip and load forces within each hand was computed to evaluate within-limb control during task performance. Data analysis algorithms related to the analysis of raw force-torque data signals, data filtering techniques, and movement onset and termination identification were based on previous work [@pone.0078934-Gorniak1], [@pone.0078934-Gorniak2], [@pone.0078934-Gorniak3].

Statistics {#s2e}
----------

The data are presented in the text and figures as means and standard errors. Analyses of variance (ANOVAs) were performed on the data with the factors of: *Method* (two levels; Rotation and Non-Rotation), and *Task* (two levels; Connect and Disconnect), *Stimulation* (three levels; Clinical, Model, and Off), and *Transducer* (two levels; Static and Dynamic). Evaluation of conditions appropriate for parametric analyses were performed prior to statistical analyses. For all ANOVAs, the assumption of sphericity was verified using Mauchly's sphericity test. If sphericity was violated, the degrees of freedom were adjusted as necessary using Greenhouse-Geisser corrections. Correlation coefficient (*r*) values from the regression analysis were subjected to Fisher z-transformation to mitigate the ceiling effects inherent to these variables. Non-transformed data are presented in the figures to avoid confusion. Post-hoc pairwise comparisons to elucidate differences among *Stimulation* (Clinical, Model, and Off) state were performed with Bonferroni corrections were used to evaluate significant effects of the ANOVA analyses. Data regarding VTA measurements were found to obey normal distributions and were therefore evaluated via paired t-tests between on-stimulation states (Clinical vs Model). Non-parametric analyses were used in the evaluation of UPDRS-III scores. Kruskal-Wallis analyses were used to determine if differences existed in UPDRS scores across the three stimulation states. Mann-Whitney tests were then used to determine differences in UPRS-III scores between stimulation states (Clinical vs Model, Clinical vs Off, and Model vs Off). All ANOVAs were performed using SPSS; all non-parametric analyses were performed using Minitab, due to ease of usability of the interface for non-parametric analyses.

Results {#s3}
=======

UPDRS-III Scores {#s3a}
----------------

UPDRS-III scores for each of the DBS states revealed differences between the on-DBS states versus the off-DBS state (K = 16.04, p\<0.001). Both clinically-determined and model-derived parameters were associated with lower overall UPDRS-III scores as compared to off-stimulation (Clinical vs Off: W = 147.0, p\<0.005; Model vs Off: W = 151.1, p\<0.001), see [Figure 2A](#pone-0078934-g002){ref-type="fig"}. No difference between the on-stimulation states was detected (Clinical vs Model: W = 120.5, p = 0.26). UPDRS-III scores associated with hand function (hand resting and action tremor, upper extremity rigidity, finger taps, hand grips, and hand pronation/supination) also revealed lower scores for on-DBS states versus the off-DBS state (K = 12.93, p\<0.001). Similar to the overall UPDRS-III scores, no difference between on-DBS states were detected (Clinical vs Model: W = 122.0, p = 0.21)., while both clinically-determined and model-derived parameters were associated with lower scores as compared to off-stimulation (Clinical vs Off: W = 139.5, p\<0.01; Model vs Off: W = 148.0, p\<0.005), also shown in [Figure 2A](#pone-0078934-g002){ref-type="fig"}.

![Mean and standard error UPDRS-III scores and task time.\
***A:*** Fine and total UPDRS-III scores. Significant reductions in both the fine and total UPDRS-III scores were found for the on-stimulation states as compared to the Off DBS state. ***B:*** Task time, averaged across stimulation state. A significant decrease in task time in Non-Rotational actions and in Disconnect-type tasks were found as compared to Rotational actions and Connect-type tasks.](pone.0078934.g002){#pone-0078934-g002}

Task Time {#s3b}
---------

The overall time to perform the bimanual tasks (task time) was not different across DBS conditions. Similar to analysis of healthy young individuals [@pone.0078934-Gorniak2] and healthy older adults [@pone.0078934-Gorniak3], task time was affected by the *Task* and *Method*. Task time was greater when the two objects were being connected to each other (*Task:* F~1,68~ = 14.2, p\<0.001) and during rotational actions (*Method:* F~1,68~ = 25.8, p\<0.001), illustrated in [Figure 2B](#pone-0078934-g002){ref-type="fig"}. While task time increased when the two objects were being connected together; this effect was particularly striking when rotational actions were used. No interaction effects were found.

Kinetics {#s3c}
--------

### Applied Forces {#s3c1}

Across all conditions, the average grip force produced was 11.6±0.9 N and 15.7±1.0 N for the static and dynamic transducers, respectively. Average grip force was affected by DBS stimulation state and transducer, as shown in [Figure 3A](#pone-0078934-g003){ref-type="fig"}. Average grip force production exhibited by participants during testing with Clinical DBS parameters was significantly greater compared to the Off DBS condition (*Stimulation*: F~1.3,134.6~ = 7.4, p\<0.005), confirmed by post-hoc analysis. Average grip force during testing with Model DBS parameters was not significantly different from Clinical or Off DBS conditions. Average grip forces were also found to be greater when exerted on the dynamic transducer (*Transducer*: F~1.0,134.6~ = 49.6, p\<0.001). The disproportion of applied grip forces between the two transducers was most notable during the Off DBS stimulation condition. This finding was confirmed by the presence of a *Stimulation x Transducer* interaction (F~1.98,134.6~ = 4.9, p\<0.01), illustrated in [Figure 3A](#pone-0078934-g003){ref-type="fig"}.

![Mean and standard error of force production.\
Significant differences in the forces exerted on the two transducers (Dynamic vs Static) are shown in each panel. Significant differences among the three DBS parameter conditions can be found in panels A-C, whereas a difference between transducers is shown in panel D. ***A:*** Average grip force. ***B:*** Rate of grip force production. ***C:*** Maximum grip force. ***D:*** Within-hand grip-load force correlation.](pone.0078934.g003){#pone-0078934-g003}

Similar to the average grip force findings, maximum grip force was significantly larger on the dynamic transducer (*Transducer:* F~1.0,122.9~ = 61.6, p\<0.001) and during the Clinical DBS condition (*Stimulation*: F~1.4,122.9~ = 10.2, p\<0.001). Maximal grip force was largest during the Clinical DBS condition as compared to the Off DBS condition, whereas the Model DBS condition did not differ from the other two stimulation states, confirmed via post-hoc. An imbalance in applied maximum applied grip force between the two transducers was most notable during the Off DBS state, such that larger maximal grip forces were applied to the dynamic transducer, confirmed by the *Stimulation x Transducer* interaction (F~1.8,122.9~ = 7.1, p\<0.005), illustrated in [Figure 3C](#pone-0078934-g003){ref-type="fig"}.

The rate of grip force production (dFG/dt) exhibited similar trends to average and maximal grip force production, such that dFG/dt was significantly larger on the dynamic transducer (*Transducer:* F~1.0,118.6~ = 133.1, p\<0.001) and when participants were experiencing the Clinical DBS condition (*Stimulation*: F~1.3,32.3~ = 9.8, p\<0.001); however, no interaction effects were found, as shown in [Figure 3B](#pone-0078934-g003){ref-type="fig"}. Post hoc analysis indicated that during the Clinical DBS condition, dFG/dt was significantly larger than dFG/dt associated with the Model DBS and Off DBS conditions.

### Kinetic Coupling {#s3c2}

In this analysis of within-hand coordination, the kinetic coupling measures did not show effects of stimulation state. Despite lack of a stimulation effect, within-hand grip-load force correlation was larger for the static transducer (*Transducer:* F~1.0,135.1~ = 25.5, p\<0.001) and in non-rotation tasks (*Method:* F~1,68~ = 12.0, p\<0.001), shown in [Figure 3D](#pone-0078934-g003){ref-type="fig"}. The difference between the grip-load correlation during use of the rotation and non-rotation methods was most pronounced on the dynamic transducer, confirmed by the *Transducer x Method* interaction (F~1.0,135.1~ = 4.9, p\<0.05).

### Volume of Tissue Activated by DBS {#s3c3}

The VTAs for the Clinical and Model DBS are located in [Table 3](#pone-0078934-t003){ref-type="table"}. The total VTA and VTA outside the subthalamic nucleus were not affected by stimulation setting in this patient population; however, the VTA inside the subthalamic nucleus was found to be largest in the Clinical settings (t~19~ = 2.28, p\<0.05).

10.1371/journal.pone.0078934.t003

###### Mean (SD) volume of tissue activated by the clinically-determined and patient-specific model-derived stimulation parameters, averaged across all patients.

![](pone.0078934.t003){#pone-0078934-t003-3}

                                ClinicalSettings    ModelSettings     *Signif.*
  ---------------------------- ------------------ ----------------- --------------
  Inside STN Volume (mm^3^)     **25.5 (17.5)**    **17.1 (11.3)**   ***p\<.05***
  Outside STN Volume (mm^3^)      40.1 (24.9)        38.3 (10.3)          --
  Total VTA (mm^3^)               65.5 (34.5)        55.4 (12.2)          --

Note that STN refers to the subthalamic nucleus.

Discussion {#s4}
==========

In this investigation of the effects of DBS on fine motor control, we hypothesized DBS would improve basic features of bimanual dexterity. Specifically, we hypothesized that testing clinically-determined and patient-specific model-derived DBS parameters would be associated with reduced bradykinesia and improved grip force production (Hypotheses 1 and 2, respectively). With respect to these hypotheses, analysis of the current data set did not reveal significant DBS-related improvements in bradykinesia during bimanual tasks; however, stimulation condition did affect the magnitude of grip forces exerted. Consistent with our third hypothesis, grip-load coupling was found to be intact in PD patients independent of treatment state. As per our fourth hypothesis, we expected both clinically-determined and model-derived DBS stimulation conditions to be associated with lower overall UPDRS-III motor scores as compared to the off-stimulation condition. Despite the limited stimulation effects on bimanual actions, significant differences in UPDRS-III scores were found. In the following paragraphs, we address the differential effects of DBS condition on motor function as well as the physiological and programming implications of DBS.

Task Performance and Effects of Stimulation State {#s4a}
-------------------------------------------------

Regarding our hypotheses, a prominent feature of PD movement, bradykinesia (measured by task time), was not different across stimulation conditions, contrary to earlier reports [@pone.0078934-Alberts3]. The lack of comparative bradykinetic hand action across stimulation states may be due to the convergence of several factors. The current study investigated bilaterally implanted DBS patients, whereas earlier studies only investigated unilaterally implanted DBS patients [@pone.0078934-Alberts3]. Symmetry in DBS implantation may have functional implications, such that modified neural output of the basal ganglia from both hemispheres may be used to improve rhythmic activities, such as gait, but not discrete movements [@pone.0078934-Alberts3], [@pone.0078934-Bastian1]. The lack of improved bradykinesia may also be due to the tasks being performed at self-selected speeds. Movement slowness emerges when PD patients are required to perform tasks at maximal speeds [@pone.0078934-Gordon2], [@pone.0078934-Gordon3]; whereas the tasks in this study were performed at self-selected speeds, consistent with performance of activities of daily living. Performance of daily tasks such as bathing, grooming, and feeding typically occur at self-selected speeds; suggesting that bradykinesia in such tasks may not be alleviated by DBS implantation and stimulation. In contrast, the lack of stimulation effects on grip-load coupling is consistent with PD patients retaining the ability to coordinate forces exerted on hand-held objects despite difficulty in other measures of motor function [@pone.0078934-Fellows2]--[@pone.0078934-Ingvarsson1].

Despite these findings, differences in grip force production due to stimulation state were exhibited. Abnormal grip force production has been reported with PD [@pone.0078934-Fellows2], [@pone.0078934-Ingvarsson1]; however, discrepancies in the effect of DBS grip force production in PD have emerged [@pone.0078934-Wenzelburger1], [@pone.0078934-Fellows3]. Consistent with earlier reports [@pone.0078934-Fellows3], clinically-determined DBS parameters were associated with increased grip force magnitude and production rates compared to the off-stimulation state. Grip data collected during the patient-specific model-derived DBS parameters condition was not significantly different from either the clinically-determined DBS condition or the off-stimulation condition, suggesting that specific aspects of these parameters may limit improvement in fine motor function despite overall improvements in gross motor function.

Possible Physiological Mechanisms and Implications for DBS Programming {#s4b}
----------------------------------------------------------------------

In the current study, clinically-determined and patient-specific model-derived DBS parameters both produced improved clinical rating scores. However, patient-specific model-derived DBS parameters do not appear to be as effective in improving motor performance in ADL-like tasks compared to clinically-determined DBS parameters. While previous work has shown equivalence in motor performance between the two parameter groups under dual-task conditions (i.e. simultaneous performance of a cognitive and motor task) [@pone.0078934-Frankemolle1], improvement with patient-specific model-derived DBS parameters has been associated with smaller VTAs due to model-based volume prediction, and, theoretically minimal spread of current to non-motor regions of the subthalamic nucleus. Consistent with [@pone.0078934-Frankemolle1], smaller VTAs within the subthalamic nucleus were found in the current data set with patient-specific model-derived DBS parameters as compared to clinically-determined parameters. As the general target of stimulation for subthalamic DBS is the dorsolateral subthalamic nucleus [@pone.0078934-RodriguezOroz1], smaller activation volumes of this motor area in the subthalamic nucleus with model-derived parameters would lead to more localized neural stimulation within the subthalamic nucleus. Given the somatotopic organization of the subthalamic nucleus [@pone.0078934-DeLong1]--[@pone.0078934-Nambu1], it is likely that the current generated according to the model-derived parameters reached neurons associated with axial and proximal anatomic structures. The representation of axial and proximal limb areas have been found to be larger than that of distal limb areas within the subthalamic nucleus [@pone.0078934-DeLong1], [@pone.0078934-Wichmann2]--[@pone.0078934-Romanelli1]. The smaller VTAs associated with model-derived parameters may not reach the less dense and more laterally located neurons associated with fine coordination of distal musculature, such as the neurons associated with finger and hand actions, producing a potential trade-off in cognitive-motor function with DBS. Future work in optimizing model-derived VTAs to affect only motor regions of the subthalamic nucleus may alleviate this trade-off by improving cognitive function while not compromising motor function in implanted DBS patients. This may be partially accomplished by utilizing measures of fine motor action performed by the distal musculature as a means to evaluate motor performance in the process of selecting the patient-specific model-derived DBS parameters. This would represent a hybrid approach to DBS programming where the patient-specific model-derived parameters define the initial starting point, while clinical input and quantitative data are used to establish final settings [@pone.0078934-Gorniak1].
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